iShares Biotechnology ETF
288 hedge funds and large institutions have $4.56B invested in iShares Biotechnology ETF in 2014 Q1 according to their latest regulatory filings, with 55 funds opening new positions, 90 increasing their positions, 96 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
6% less repeat investments, than reductions
Existing positions increased: 90 | Existing positions reduced: 96
17% less call options, than puts
Call options by funds: $614M | Put options by funds: $735M
Holders
288
Holding in Top 10
20
Calls
$614M
Puts
$735M
Top Buyers
| 1 | +$216M | |
| 2 | +$210M | |
| 3 | +$188M | |
| 4 |
Mirae Asset Global Investments
Seoul,
South Korea
|
+$165M |
| 5 |
Goldman Sachs
New York
|
+$156M |
Top Sellers
| 1 | -$55.1M | |
| 2 | -$43.2M | |
| 3 | -$33.8M | |
| 4 |
BTS
BB&T Securities
Richmond,
Virginia
|
-$31.9M |
| 5 |
SG Americas Securities
New York
|
-$18.3M |